On April 29, the U.S. Food and Drug Administration (FDA) announced its Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in June to consider the submissions of emergency use authorization requests from Moderna and Pfizer for their COVID-19 vaccines for young children. The FDA said it plans to convene the panel of vaccine experts on June 8, 21, and 22 to review the applications. For now, the dates are tentative. The FDA stated that it will provide more details as each company completes its application.
Stay Informed on the Latest Research & Analysis from ANCOR